TOP1 and cancer: The TOP1-cleavage complex (TOP1-cc) stabilized by camptothecin (CPT) is adverse to the normal function of TOP1 but can be degraded by the CRL3-mediated neddylation–UPS pathway, thus eliciting cancer cell tolerance [76].